USA towards cosmetic manufacturing are a major driving force for the CMO/CDMO market growth.

NEWARK, DE, UNITED STATES, February 17, 2025 /EINPresswire.com/ -- The CMO/CDMO market is poised for significant growth, with projections indicating a robust market size of USD 39.4 billion by 2033. This represents a substantial increase from USD 22.5 billion in 2023, driven by a Compound Annual Growth Rate (CAGR) of 5.7% over the next decade.

This growth reflects the increasing outsourcing trend within the pharmaceutical industry, as companies seek to enhance operational efficiency by partnering with specialized organizations that can provide critical services.

A recent industry analysis underscores the pivotal role of CMOs and CDMOs in the pharmaceutical value chain. As pharmaceutical companies continue to focus on innovation and core competencies, the demand for outsourcing services has surged. This trend has positioned CMOs and CDMOs as key players, offering expertise in drug development, manufacturing, and regulatory compliance—allowing their clients to accelerate time-to-market and reduce operational costs.

𝐆𝐚𝐢𝐧 𝐀𝐜𝐜𝐞𝐬𝐬 𝐭𝐨 𝐌𝐚𝐫𝐤𝐞𝐭 𝐓𝐫𝐞𝐧𝐝𝐬: 𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐘𝐨𝐮𝐫 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭! https://www.futuremarketinsights.com/report-sample#5245502d47422d3133303338

FMI, a recognized leader in the CMO/CDMO sector, is strategically positioned to capitalize on this dynamic market opportunity. With a foundation built on innovation, a commitment to operational excellence, and a deep understanding of the pharmaceutical landscape, FMI is primed to lead the way in supporting pharmaceutical companies in their evolving needs.

As the pharmaceutical industry continues to evolve, the significance of CMOs and CDMOs will only increase. With its strategic positioning and forward-thinking approach, FMI is ready to navigate the future of the pharmaceutical industry, delivering tailored solutions to meet the challenges and capitalize on the opportunities that lie ahead.

𝐊𝐞𝐲 𝐓𝐚𝐤𝐞𝐚𝐰𝐚𝐲𝐬

• The global CMO/CDMO market grew at a CAGR of 5.3% over the historical period.

• The Indian market is expected to expand at a CAGR of 5% in the coming decades.

• In 2022, North America held more than 17.6% of the global revenue share.

• The Chinese market is expected to grow at a CAGR of 5% over the next few decades.

• In 2022, the contract manufacturing segment held 69.28% of the market share.

“The growing demand for outsourcing in the pharmaceutical industry offers us a unique opportunity to expand our services and reinforce our leadership in the CMO/CDMO market,” said an FMI representative. “We are dedicated to leveraging our extensive expertise and cutting-edge capabilities to support the pharmaceutical sector and its future advancements.”

𝐑𝐢𝐬𝐢𝐧𝐠 𝐃𝐞𝐦𝐚𝐧𝐝 𝐟𝐨𝐫 𝐌𝐚𝐫𝐤𝐞𝐭 𝐃𝐚𝐭𝐚: 𝐎𝐮𝐫 𝐅𝐮𝐥𝐥 𝐑𝐞𝐩𝐨𝐫𝐭 𝐎𝐟𝐟𝐞𝐫𝐬 𝐃𝐞𝐞𝐩 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐚𝐧𝐝 𝐓𝐫𝐞𝐧𝐝 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬! https://www.futuremarketinsights.com/reports/cmo-cdmo-market

𝐂𝐨𝐦𝐩𝐞𝐭𝐢𝐭𝐢𝐯𝐞 𝐋𝐚𝐧𝐝𝐬𝐜𝐚𝐩𝐞

The CMO/CDMO market is characterized by a consolidated vendor landscape, with ongoing research and development remaining a key strategy among market players. Strategic collaborations are also a common approach used to gain a competitive advantage.

• In July 2022, Societal CDMO and Lannett Firm revised their authorization and distribution agreement for marketing Verapamil PM and Verelan SR products. Societal CDMO, specializing in the development and production of small molecules, is expected to see both immediate and long-term price increases in development, in conjunction with a ten percent increase in the revenue share from Verapamil PM sales.

• In June 2022, MilliporeSigma, the U.S. and Canada Life Science enterprise of Merck KGaA, doubled its capacity for producing high-potent active pharmaceutical ingredients (HPAPI) with the establishment of a new facility in Verona, near Madison, WI. The USD 65 million, 70,000-square-foot facility will employ 50 individuals in the community.

𝐊𝐞𝐲 𝐂𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐏𝐫𝐨𝐟𝐢𝐥𝐞𝐝

• Swiss American CDMO
• Pierre Fabre Group
• Zymo Cosmetics
• Fareva, Biofarma Srl C.F
• Chemineau, C.O.C.
• Farmaceutici Srl
• Paragon Nordic Cosmetic Solutions
• Kolma
• Lonza
• Cho Chuang Industrial Co., Ltd.
• Vive Cosmetics
• Ori BioNature Sdn Bhd
• Zoic Cosmetics
• Samriddhi Life Sciences
• Natrocare

𝐆𝐞𝐭 𝐘𝐨𝐮𝐫 𝐇𝐚𝐧𝐝𝐬 𝐨𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐏𝐫𝐨𝐣𝐞𝐜𝐭𝐢𝐨𝐧𝐬 𝐍𝐨𝐰! https://www.futuremarketinsights.com/industry-analysis/healthcare-services

𝐊𝐞𝐲 𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐬 𝐏𝐫𝐨𝐟𝐢𝐥𝐞𝐝 𝐢𝐧 𝐭𝐡𝐞 𝐂𝐌𝐎/𝐂𝐃𝐌𝐎 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭

𝐁𝐲 𝐒𝐞𝐫𝐯𝐢𝐜𝐞:

• Contract Development
o Formulation development
o Pilot studies

• Contract Manufacturing
o Bulk preparation & scale-up
o Safety Testing
o Filling & Packaging
o Close jars
o Bottles
o Tubes
o Roll-ons

• Others

𝐁𝐲 𝐏𝐫𝐨𝐝𝐮𝐜𝐭:

• Hair Products
• Skin Products
• Lip Products
• Eye Products
• Body Hygiene
• Oral Hygiene

𝐁𝐲 𝐅𝐨𝐫𝐦:

• Solid Form & Powder
• Lotions
• Creams
• Others

𝐁𝐲 𝐑𝐞𝐠𝐢𝐨𝐧:

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East & Africa

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐅𝐌𝐈’𝐬 𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐎𝐧𝐠𝐨𝐢𝐧𝐠 𝐂𝐨𝐯𝐞𝐫𝐚𝐠𝐞 𝐨𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐃𝐨𝐦𝐚𝐢𝐧:

𝐁𝐢𝐨𝐩𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥 𝐂𝐨𝐧𝐭𝐫𝐚𝐜𝐭 𝐌𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐆𝐫𝐨𝐰𝐭𝐡 – 𝐓𝐫𝐞𝐧𝐝𝐬 & 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝟐𝟎𝟐𝟒-𝟐𝟎𝟑𝟒: https://www.futuremarketinsights.com/reports/biopharmaceutical-contract-manufacturing-market

𝐇𝐢𝐠𝐡 𝐏𝐨𝐭𝐞𝐧𝐜𝐲 𝐀𝐏𝐈 𝐂𝐨𝐧𝐭𝐫𝐚𝐜𝐭 𝐌𝐚𝐧𝐮𝐟𝐚𝐜𝐭𝐮𝐫𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 – 𝐓𝐫𝐞𝐧𝐝𝐬 & 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝟐𝟎𝟐𝟐-𝟐𝟎𝟑𝟐: https://www.futuremarketinsights.com/reports/high-potency-api-contract-manufacturing-market

𝐏𝐫𝐞𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐃𝐞𝐯𝐢𝐜𝐞 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 𝐒𝐞𝐫𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 𝐛𝐲 𝐂𝐨𝐧𝐬𝐮𝐥𝐭𝐢𝐧𝐠 𝐚𝐧𝐝 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 𝐒𝐞𝐫𝐯𝐢𝐜𝐞𝐬, 𝐭𝐡𝐫𝐨𝐮𝐠𝐡 𝟐𝟎𝟑𝟓: https://www.futuremarketinsights.com/reports/preclinical-medical-device-testing-services-market

𝐎𝐮𝐭𝐬𝐨𝐮𝐫𝐜𝐞𝐝 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 𝐒𝐞𝐫𝐯𝐢𝐜𝐞𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 – 𝐓𝐫𝐞𝐧𝐝𝐬 & 𝐅𝐨𝐫𝐞𝐜𝐚𝐬𝐭 𝟐𝟎𝟐𝟓-𝟐𝟎𝟑𝟓: https://www.futuremarketinsights.com/reports/outsourced-testing-services-market

𝗛𝗼𝗺𝗲 𝗦𝗹𝗲𝗲𝗽 𝗔𝗽𝗻𝗲𝗮 𝗧𝗲𝘀𝘁𝗶𝗻𝗴 𝗠𝗮𝗿𝗸𝗲𝘁 𝗚𝗿𝗼𝘄𝘁𝗵 – 𝗜𝗻𝗱𝘂𝘀𝘁𝗿𝘆 𝗙𝗼𝗿𝗲𝗰𝗮𝘀𝘁 𝟮𝟬𝟮𝟱-𝟮𝟬𝟯𝟱: https://www.futuremarketinsights.com/reports/home-sleep-apnea-testing-market

𝐀𝐛𝐨𝐮𝐭 𝐅𝐮𝐭𝐮𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 (𝐅𝐌𝐈)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Ankush Nikam
Future Market Insights, Inc.
+91 90966 84197
email us here
Visit us on social media:
Facebook
X
LinkedIn
YouTube

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.